Citation data

CrossRef

Works that cite this article, indexed by Crossref.

8 resultsUpdated October 18, 2026

Seroprevalence of Bordetella pertussis among a nationally representative sample of Iranian pediatric population

Journal of Research in Medical Sciences 26(1) (2021)

Zary Nokhodian; Behrooz Ataei; Seyed Mohsen Zahraei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Roya Kelishadi

Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants

Seminars in Respiratory and Critical Care Medicine 46(01) (2025)

Nisha Makan-Murphy; Shabir A Madhi; Ziyaad Dangor

Childhood pertussis is still here: An Asian city's perspectives

Pediatric Pulmonology 57(4) (2022)

Kam Lun E. Hon; Yee Ming Jennifer Li; Alexander K. C. Leung; Alex H. C. Wong; Karen Ka Yan Leung; Daniel K. K. Ng

Identification of Etiological Agents of Pertussis-Like Syndrome in Children Younger Than 5 Years Old Hospitalized in Southwestern Iran

Jundishapur Journal of Microbiology 16(8) (2023)

Ahmad Shamsizadeh; Roya Nikfar; Elham Bavarsadiankhah; Effat Abbasi-Montazeri; Niloofar Neisi; Maniya Arshadi

Genetic variability of Bordetella pertussis and its role in vaccine prevention of pertussis

Journal of microbiology, epidemiology and immunobiology 96(4) (2019)

I. G. Bazhanova; M. V. Britsina; N. U. Mertsalova; M. N. Ozeretskovskaya

Prevention of aggregate formation through mechanism analysis in refolding of recombinant pertactin from Escherichia coli

Process Biochemistry 62 (2017)

Zenglan Li; Chun Zhang; Yan Zhang; Yongdong Liu; Xiunan Li; Guanghui Ma; Jian Luo; Zhiguo Su

Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran

PLOS ONE 15(9) (2020)

Gaelle Noel; Farzad Badmasti; Vajihe S. Nikbin; Seyed M. Zahraei; Yoann Madec; David Tavel; Mohand Aït-Ahmed; Nicole Guiso; Fereshteh Shahcheraghi; Fabien Taieb; Abdallah M. Samy

Immunogenicity and safety of DTPW-HEPB-HIB (PRP-T) vaccine (Pentavac) in infants aged 2–7 months: a post marketing phase 4 clinical trial study

Russian Journal of Infection and Immunity 14(4) (2024)

H. Masoumi-Asl; A. Nateghian; H.R. Baradaran; E. Jafari; R. Azizian; Mahmoud Faramarzi